Herbert J. Conrad

Former President Roche Pharmaceuticals US

Mr. Conrad became a Director of Celldex in March 2004. Mr. Conrad was the former president of Roche Pharmaceuticals in the United States from 1982 until his retirement in 1993. Since then he has served on the boards of Dura, UroCor, Sicor, GenVec (chairman), Bone Care International (chairman) and was a co-founder of Reliant Pharmaceuticals. Mr. Conrad is currently chairman of Sapphire Therapeutics and is on the boards of Savient Pharmaceuticals, Pharmasset Inc., and Symphony Evolution. He received B.S. and M.S. degrees from Brooklyn College of Pharmacy and an honorary Doctorate in Humane Letters from Long Island University.